Trial Profile
Phase II proof-of-concept study of dextromethadone in patients with neuropathic pain
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Esmethadone (Primary)
- Indications Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Relmada Therapeutics
- 07 Dec 2015 According to a Relmada Therapeutics media release, this study is expected to start in first-half of 2016.
- 09 Dec 2014 Status changed from not stated to planning.
- 08 Dec 2014 New trial record